Role and Modulation of NK Cells in Multiple Myeloma

Myeloma tumor cells are particularly dependent on their microenvironment and sensitive to cellular antitumor immune response, including natural killer (NK) cells. These later are essential innate lymphocytes implicated in the control of viral infections and cancers. Their cytotoxic activity is regul...

Full description

Bibliographic Details
Published in:	Hemato
Main Authors:	Marie Thérèse Rubio, Adèle Dhuyser, Stéphanie Nguyen
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Subjects:	myeloma NK cells immunomodulation cell therapy immunotherapy
Online Access:	https://www.mdpi.com/2673-6357/2/2/10

Similar Items

Role of NK Cells in Progression and Treatment of Multiple Myeloma
by: Iman Chanchiri, et al.
Published: (2025-04-01)

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients
by: Chantal Reina-Ortiz, et al.
Published: (2021-01-01)

Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
by: Jingjing Pu, et al.
Published: (2024-10-01)

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
by: Chantal Reina-Ortiz, et al.
Published: (2022-01-01)

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment
by: Son Hai Vu, et al.
Published: (2023-11-01)

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival
by: Rao Prabhala, et al.
Published: (2023-12-01)

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma
by: Michael W. Moles, et al.
Published: (2024-06-01)

Single VHH-directed BCMA CAR-NK cells for multiple myeloma
by: Quan Ren, et al.
Published: (2023-11-01)

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
by: Kerry S. Campbell, et al.
Published: (2018-11-01)

Proportional and functional anomalies of CD38+ NK Cells:A new mechanism for impaired anti-tumour immunity in multiple myeloma?
by: Huixian Chen, et al.
Published: (2025-09-01)

Combination immune therapies to enhance anti-tumor responses by NK cells
by: Ashley Mentlik James, et al.
Published: (2013-12-01)

NK cell-based tumor immunotherapy
by: Hao Zhang, et al.
Published: (2024-01-01)

Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis
by: Mei N, et al.
Published: (2024-06-01)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
by: Suthida Panwong, et al.
Published: (2021-10-01)

Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
by: Marina Gergues, et al.
Published: (2025-04-01)

Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
by: Maria C. Ochoa, et al.
Published: (2019-07-01)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
by: Xinyu Wu, et al.
Published: (2022-12-01)

New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01)

Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles
by: Kwang-Soo Kim, et al.
Published: (2021-04-01)

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
by: Renato Zambello, et al.
Published: (2020-03-01)

NK cells in renal cell carcinoma and its implications for CAR-NK therapy
by: Xinwei Li, et al.
Published: (2025-02-01)

Possibilities of using NK cells in cancer immunotherapy
by: Paulina Kwaśnik, et al.
Published: (2020-03-01)

The Role of Immunotherapy in Multiple Myeloma
by: Mehmet Kocoglu, et al.
Published: (2016-01-01)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
by: Loredana Cifaldi, et al.
Published: (2023-06-01)

Rescue SLAMF7 activity in exhausted natural killer cells: Novel challenges in the immunotherapy of multiple myeloma
by: Alessandra Zingoni, et al.
Published: (2022-12-01)

PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival
by: Jeremiah L. Oyer, et al.
Published: (2024-04-01)

CAR-NK cell therapy: promise and challenges in solid tumors
by: Sahar Balkhi, et al.
Published: (2025-04-01)

Correction: PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival
by: Jeremiah L. Oyer, et al.
Published: (2025-07-01)

Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma
by: Anna Mansour, et al.
Published: (2017-08-01)

CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects
by: Winston Hibler, et al.
Published: (2023-11-01)

CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
by: Wangshu Li, et al.
Published: (2024-08-01)

CAR-NK cell therapy for glioblastoma: what to do next?
by: Qi Xiong, et al.
Published: (2023-06-01)

Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery
by: Hyelee Kim, et al.
Published: (2025-05-01)

Immunotherapy with NK cells: recent developments in gene modification open up new avenues
by: Lisa Marie Reindl, et al.
Published: (2020-01-01)

Chasing Uterine Cancer with NK Cell-Based Immunotherapies
by: Vijay Kumar, et al.
Published: (2022-12-01)

Identification of the CD16low CD56low CD38pos Natural Killer Cell as a Key Subset in Patients with Multiple Myeloma
by: Ting Chen, et al.
Published: (2022-12-01)

Immunotherapy for the treatment of multiple myeloma
by: Leora S. Boussi, et al.
Published: (2022-10-01)

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
by: Faroogh Marofi, et al.
Published: (2021-03-01)

Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells
by: Jun-Hui Guo, et al.
Published: (2025-05-01)

The safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumors
by: Hamid Mahdizadeh, et al.
Published: (2025-05-01)